Market Overview

From Earlier: Illumina Launches Infinium HumanCore Arrays for Economical Large-Scale Genetic Studies

Share:
Related ILMN
Benzinga's Top Upgrades
Morgan Stanley Upgrades Illumina To Overweight
Health, Biotech Mutual Funds Set The Pace For Broad Gains In May (Investor's Business Daily)

Illumina, Inc. (NASDAQ: ILMN) today launched the Infinium HumanCore BeadChip family of products. With content developed in collaboration with several leading research institutions, the customizable Infinium HumanCore and Infinium HumanCoreExome BeadChips support cost-effective, large-scale genotyping and screening studies such as those performed by biobanks, genome centers, and core labs. Based on Illumina's proven Infinium assay, the BeadChips enable genotyping of markers found across diverse populations, making them ideal for researchers engaged in population genetics studies around the world.

Posted-In: News FDA

 

Related Articles (ILMN)

Around the Web, We're Loving...

Get Benzinga's Newsletters